David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 78,796 shares at $31.96 ($2.6M) on 2021-05-19, disclosed to the SEC on 2021-05-21.
Open-market sale of $2.6M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.96 | 17,269 | $552K | 21.5% |
| 2 | $31.96 | 17,269 | $552K | 21.5% |
| 3 | $32.78 | 16,020 | $525K | 20.4% |
| 4 | $32.78 | 16,020 | $525K | 20.4% |
| 5 | $33.38 | 3,229 | $108K | 4.2% |
| 6 | $33.38 | 3,229 |
| $108K |
| 4.2% |
| 7 | $33.76 | 899 | $30K | 1.2% |
| 8 | $34.93 | 2,278 | $80K | 3.1% |
| 9 | $34.93 | 2,278 | $80K | 3.1% |
| 10 | $35.27 | 305 | $11K | 0.4% |
| Total | $32.61 avg | 78,796 | $2.6M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-04-07 | $2.9M | — | Filing → |